Medindia

X

Following Its Recent Approval in the United States and Europe for Osteoporosis, Prolia Will Garner Sales of More than $500 Million in 2019

Tuesday, July 6, 2010 General News J E 4
Advertisement
Prolia's Uptake Will Be Constrained by Its Premium Price and the Increasing Availability of Generic Drugs, According to Findings from Decision Resources

For more information, contact:

Decision Resources, Inc.

Christopher Comfort

781-296-2597

ccomfort@dresources.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Fact or Fiction: Will Carrots Improve Your Eyesigh...
S
Global Health Leader, PSI, Launches Impact Magazin...